To first assess the potential of 4’-FlU to pharmacologically manage influenza in high-risk hosts, we infected interferon α/β receptor knockout (IFNAR1 KO) and V(D)J recombination activation gene RAG-1 KO mice with pdmCa09. This evidence concerns the gene IFNAR1 and influenza.